EP0459377A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Use of E1 prostaglandin to cure male erectile inpotence
Assignee: Individual
•
Filing: 1991-05-28
•
Granted: —
•
Expires: 2011-05-28
Abstract
Abstract Use of E1 Prostaglandin (Alprostadil) in the preparation of pharmaceutical compositions for the treatment of male erectile impotence, carried out by introducing therapeutically active quantities of the medication into the corpora cavernosa of the penis.
Inventors
- 👤 Alberto Reale
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-09 22:52
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0034; A61K31/00; A61K31/557
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
18 words
Use of Prostaglandin E1 (Alprostadil) in the preparation of pharmaceutical compositions for the treatment of male erectile impotence.
Claim 2
Dependent Claim
26 words
Use as per claim 1, characterized by the fact that said compositions consist of physiological saline solutions in doses containing 10 to 50 µg of Alprostadil.
Claim 3
Dependent Claim
28 words
Use as per claim 1, characterized by the fact that said compositions consist of low alcohol content alcohol solutions, in doses containing 10 to 50 µg of Alprostadil.
Claim 4
Dependent Claim
29 words
Use as per claim 1, characterized by the fact that said compositions consist of 10 to 50 µg of Alprostadil and 1 to 5 ml of physiological saline solution.
Claim 5
Dependent Claim
31 words
Use as per claim 1, characterized by the fact that said compositions consist of 10 to 50 µg of Alprostadil and 1 to 5 ml of low alcohol content alcohol solution.
Claim 6
Dependent Claim
20 words
Use as per claim 1, characterized by the fact that said compositions are introduced in the corpora cavernosa by injection.
Claim 7
Dependent Claim
20 words
Use as per claim 1, characterized by the fact that said compositions are introduced in the corpora cavernosa by iontophoresis.
Claim 8
Dependent Claim
36 words
Method for the treatment of male erectile impotence, in which compositions consisting of E1 Prostaglandin (Alprostadil) and physiological saline solution or low alcohol content alcohol solution are introduced in the corpora cavernosa by injection or iontophoresis.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.